Abstract Low-density lipoprotein (LDL) subclass pattern B is characterized by a predominance of small, dense LDL particles (LDL peak particle size ^255 A), increased plasma triglyceride (TG) levels, reduced high-density lipoprotein (HDL) cholesterol levels, and glucose intolerance. This study tested the hypothesis that there are differences in the regulation of TG and HDL metabolism by insulin in patients with LDL pattern B. The study group comprised 160 healthy older (60±8 years, mean±SD) men. Forty-nine of the men (31%) had LDL pattern B. These men had a higher waist-to-hip ratio (WHR) (0.98±0.06 versus 0.95±0.06, P<.005) and lower maximal aerobic capacity (Vo 2 max) (P<.005) than the 111 men of comparable age with a predominance of larger LDL particles (LDL peak particle size >255 A, LDL pattern A). Men with LDL pattern B also had higher TG (1.76+0.60 versus 1.03±0.41 mmol/L, P<.0001) and lower HDL cholesterol (0.83±0.13 versus 1.06±0.29 mmol/L, P<.0001) and percent HDL 2 subspecies (by gradient gel electrophoresis) (31±4 versus 43±6, P<.0001) levels than men with LDL pattern A, but the total cholesterol and LDL cholesterol levels did not differ between groups. Fasting glucose and insulin levels also did not differ between groups, but plasma glucose and insulin levels measured at 90 and 120 minutes during an oral glucose tolerance test were E levated levels of low-density lipoprotein (LDL) cholesterol (LDL-C) and reduced levels of high-density (HDL) lipoprotein cholesterol (HDL-C) are risk factors for coronary artery disease. 1 -2 Both LDL and HDL are polymorphic and consist of different subclasses of particles of varying size, density, distribution, and composition. Most individuals can be classified on the basis of their LDL particle size distribution into one of two LDL subclass patterns.
significantly higher in men with LDL pattern B. This was associated with a higher prevalence of impaired glucose tolerance in men with LDL B compared with men with LDL A (49% versus 24%, / > <.005). The differences in lipoprotein lipid levels and glucose tolerance between groups persisted after correcting for differences (by ANCOVA) in WHR and VOjmax. Multiple linear regression analyses with interaction terms demonstrated that the regression equations delineating the relations of plasma TG and HDL to insulin levels differed significantly; men with LDL pattern B had higher plasma TG and lower HDL cholesterol levels at each plasma insulin level than men with LDL pattern A (P<.001). The relation between HDL and TG levels and body composition also differed: men with LDL pattern B had lower HDL cholesterol levels at each percent body fat (P<.005) and higher TG levels at each WHR than men with LDL pattern A (P<.001). These results suggested that glucose intolerance and genetic differences in the regulation of TG and HDL metabolism by insulin reduce plasma HDL and raise TG levels in men with small LDL particles. (ArterioscUr Thromb.
B often have reduced plasma levels of HDL-C, increased triglyceride (TG) levels, 46 and glucose intolerance/insulin resistance 79 and are at increased risk for coronary artery disease. 10 - 11 The metabolic abnormalities underlying this atherogenic lipoprotein phenotypic pattern of small LDL particles and associated low HDL-C, increased TG, glucose intolerance, and insulin resistance are not known.
Individuals with abdominal obesity often have glucose intolerance and insulin resistance, hypertension, increased plasma TG concentrations, reduced concentrations of HDL-C, 12 -14 and small LDL particles.
12
- 15 This clustering of abdominal obesity, glucose intolerance, hyperinsulinemia, dyslipidemia, and hypertension, all features of Reaven's Syndrome X, 16 suggests that insulin resistance may play a major role in the pathogenesis of LDL pattern B. Brunzell and Bierman 17 have reported an altered relation between plasma insulin and TG levels in patients with familial hypertriglyceridemia, a genetic syndrome that has many features in common with LDL pattern B. Based on these observations, we hypothesized that there might be differences in the regulation of TG and HDL metabolism by insulin in patients with LDL pattern B. This study was designed to address this hypothesis and was performed in 160 healthy middle-aged and older men on no medications and without overt disease.
Methods

Subject Recruitment, Screening, and Selection
This study was approved by the University of Maryland and the Francis Scott Key Medical Center Human Studies Institutional Review Boards, and all subjects provided informed consent before participation. Healthy nonsmoking male volunteers 46 through 79 years of age with a wide range of body mass indexes (BMIs) and physical conditioning statuses were recruited from the Baltimore-Washington metropolitan area for participation in the Fitness After Forty-Five weight loss and exercise intervention study. 18 After a review of their medical histories, men without a history of diabetes, hypertension, hyperlipemia, and coronary artery disease were invited for a medical examination. Blood chemistries, fasting lipids, and a urinalysis were performed. Exclusion criteria included hypertension (blood pressure > 140/90 mm Hg), hyperlipidemia (plasma TG or LDL-C level >90th percentile for age and gender according to the Lipid Research Ginics Center criteria 19 ), fasting glucose > 140 mg/dL, 20 anemia, or abnormalities in liver, renal, or electrolyte metabolism. Data are reported on the first 160 men who completed the metabolic studies.
Body Composition
BMI was calculated as body weight in kilograms divided by the height in meters squared. Body density was determined by hydrostatic weighing. Percent body fat was calculated after correction for the residual lung volume using the Siri equation. 21 Fat-free mass was calculated as (100-percent body fat) x body weight/100. The waist-to-hip ratio (WHR), measured as the ratio of the minimal abdominal circumference divided by the circumference at the maximal gluteal protuberance, was the index of body fat distribution.
Noninvasive Cardiac Evaluation and Measurement of Maximal Aerobic Capacity
An exercise treadmill test to >85% of the predicted ageadjusted maximal heart rate (220-age) was performed according to the Bruce protocol 22 to exclude subjects with symptomatic heart disease. On a subsequent visit, the maximal aerobic capacity (Vo^max) was determined by using a modified Balke protocol. 18 -23 The Vo 2 max is expressed in milliliters per kilogram of total body weight per minute or as milliliters per kilogram fat-free mass per minute.
Metabolic Testing
Before metabolic testing, the men were instructed over a 6-week period by registered dietitians in the principles of an American Heart Association (AHA) step I Diet 24 followed by 4 weeks of dietary and weight stabilization. Adherence was monitored by review of 7-day food records. To further control for the effects of variation in diet on lipoprotein lipids and glucose metabolism, for 4 days before and during metabolic testing subjects were provided weight-maintaining AHA step I diets from the Francis Scott Key General Clinical Research Center metabolic kitchen.
Blood samples for the determination of fasting lipoprotein lipid levels were drawn into chilled EDTA-containing (1 mg EDTA/1 mL blood) tubes after a 12-to 14-hour overnight fast on days 4 and 6 of the controlled metabolic diet. The reported lipoprotein lipids are the means of these two determinations. On day 4 of the metabolic diet, after the lipid samples were drawn, an oral glucose tolerance test (OGTT) at a dose of 40 g glucose/m 2 body surface area was performed in accordance with the recommendation of the Committee on Statistics of the American Diabetes Association. 25 Samples were drawn every 30 minutes over a 2-hour period for measurement of plasma glucose and insulin. Plasma glucose was measured by the glucose oxidase method using a Beckman glucose analyzer (Beckman Instruments). Plasma insulin levels (immunoreactive insulin) were measured in 153 of the men by radioimmunoassay. 26 Two-hour insulin and glucose areas were calculated by using the trapezoidal method. The glucose dose averaged 80±6 g in this population, and there were no relations between the dose of glucose administered and the 2-hour glucose level (r=.O7, P<.32), 2-hour glucose area (/-=.O5, P<.54), or 2-hour insulin concentration (r=.10, P<.20). Thus, the fact that more obese subjects received a larger adjusted dose of glucose based on body surface area had no apparent effect on their glucose and insulin responses during the OGTT and did not influence their categorization as normal, impaired, or diabetic on OGTT.
Plasma TG and cholesterol levels were measured enzymatically on an Abbott ABA 200 series bichromatic analyzer. 27 ' 28 Since none of the subjects had plasma TG >4.52 mmol/L (400 mg/dL), HDL-C was measured in the supernatant after precipitation of the apolipoprotein B-containing lipoproteins with dextran sulfate. 29 The LDL-C was calculated by using the Friedewald equation. 30 The HDL subclass distribution was measured at the Lawrence Berkeley Laboratory by using gradient gel electrophoresis (GGE) according to the method of Blanche et al. 31 Briefly, plasma in the d<\.2\ g/mL fraction was applied to Pharmacia PAA 4% to 30% slab gradient gels, electrophoresed, fixed, and stained for protein using Coomassie blue G-250. The stained gels were then scanned at 596 nm with a Transidyne RFT scanning densitometer. The scanner was interfaced with a PDP/8e computer (Digital Equipment Corp). The optical density of HDL was plotted against the relative mobility of HDL protein from the origin compared with the mobility of bovine serum albumin. Five HDL subclasses were separated using this method. 31 The relative amount of each HDL subspecies was reported as (the area in the HDL subspecies mobility interval/total HDL area) x 100%.
The LDL peak particle size was measured in all 160 men by GGE. 32 -33 Briefly, the d< 1.063 g/mL plasma fraction was applied to Pharmacia PPA 2% to 16% gradient gels, electrophoresed, fixed, and stained for protein. The stained gels were scanned, and LDL peak particle diameters were calculated from calibration curves derived from standards of known size. Based on the results of the scans, subjects were classified into one of two major LDL subclass patterns: LDL pattern B, with a peak particle diameter £255 A and with skewing toward the larger particle diameters (LDL-III and LDL-IV), and LDL pattern A, with a peak particle diameter >255 A and a skewing toward the smaller particles (LDL-I and LDL-II). One hundred fifty-seven men (98%) could be readily classified into one of these two LDL phenotypes. The other three men, who had densitometry scans with two distinct major peaks, were classified as having LDL pattern B. Twenty-five subjects had LDL peak particle diameters between 255 and 260 A (LDL-II) and would be classified by some investigators 89 as having intermediate pattern LDL. However, the results of the comparison of subjects with LDL patterns A and B and the multiple regression analyses were essentially the same when these 25 men with intermediate LDL pattern were grouped with subjects with LDL peak particle diameter >260 A, as was done in the analyses presented below, or if they were excluded from the analyses, or when they were grouped with the subjects with LDL pattern B. In 84 men the LDL subclass distribution was also measured by analytical ultracentrifugation. 34 
Statistical Methods
Data were entered into a database designed for this study on a VAX 3100 computer workstation and transferred to an SAS 35 dataset for analysis. The data were tested for kurtosis and skewness. Plasma TG levels, insulin areas, and plasma immunoreactive insulin levels at 30, 60, 90, and 120 minutes were not To determine whether the regression equations delineating the relations between the dependent variables (HDL-C, log TG) and independent variables (body composition, insulin) differed in men with LDL patterns A versus B, multiple linear regression analysis with interaction was performed 36 The regression equations for LDL patterns A and B were considered different, ie, the regression lines were not coincident, if the coefficients for either the intercept (c), slope (d), or both (c and d) were significant. All results are expressed as mean±SD. Differences at / ) <.O5 were considered significant.
Results
Physical characteristics of the 160 men are summarized in Table 1 . The LDL peak particle diameter measured by GGE ranged from 239 to 283 A with a mean diameter of 261±8 A. The LDL peak particle size measured by GGE and the peak flotation rate as measured by analytical ultracentrifugation were highly correlated (r=.81, F<.0001). Therefore, the smaller LDL particles were less buoyant than the larger LDL particles.
On the basis of our previous classification, the men were divided into those with LDL patterns B and A. Forty-nine of the men (31%) had an LDL peak particle size ^255 A, consistent with LDL pattern B. The men with LDL pattern B had a lower Vc^max (/ > <.005) and a higher WHR (P<.005) than the men with LDL pattern A ( Table 1 ). The age, BMI, and percent body fat did not differ between the two groups.
Total cholesterol and LDL-C were similar in both groups (Table 2) . However, the men with LDL pattern B had significantly higher TG levels than men with LDL pattern A (1.76±0.60 versus 1.03±0.41 mmol/L, / > <.0001). Plasma levels of HDL-C were significantly The HDL^ and HDL^ subclasses as measured by GGE were also lower (31±4% versus 43±6%, P<.0001) in men with LDL pattern B (Table 3) . Univariate analyses revealed a negative correlation between LDL peak particle size and log 10 TG (r=-.68, /><.OO01) and positive correlations between LDL peak particle size and both HDL-C (r=.53, /><.0001) and the HDL 2 subspecies (r=.57, P<.0001).
Because men with LDL pattern B had a higher WHR and lower Vo 2 max than men with LDL pattern A, it was possible that the observed higher TG and lower HDL levels in men with LDL pattern B could be due to differences in body composition and cardiovascular fitness. ANCOVA was used to compare lipoprotein lipid levels between the two groups. After adjustment for WHR and Vo 2 max, the differences in plasma TG (1.70±0.70 versus l.ll±0.40 mmol/L, P<.0001) and HDL-C (0.83±0.17 versus 0.96±0.21 mmol/L, f<.0001) levels persisted between the two groups. This suggests that factors other than differences in body composition and Vo 2 max contribute to the dyslipoproteinemia in men with small LDL particles.
LDL Pattern and Glucose Metabolism
To determine whether the increase in plasma TG and reduction in HDL-C levels in men with LDL pattern B were related to the hyperinsulinemia and glucose intolerance often present in men with abdominal obesity, the plasma glucose and insulin responses during an OGTT were measured. Fasting plasma glucose levels were the same in both groups (Table 2 ), but plasma glucose levels at 90 and 120 minutes as well as the glucose areas were significantly higher in men with LDL pattern B than LDL pattern A (Z'<.005). Fasting insulin levels (immunoreactive insulin) were also the same in both groups, but plasma insulin levels at 90 and 120 minutes were higher in men with LDL pattern B (P<.05). In these subjects, LDL size was correlated weakly with fasting plasma glucose (r=-.16,/'<.05), glucose at 120 minutes (r=-.27, P<.001), and glucose area (r=-.24, P<.005). A significant inverse relation was present between LDL size and log 10 insulin area (r= -.22, Z'<.01) but not with fasting plasma insulin levels (r=-.10, P<.53). Thus, although there were statistically significant relations between LDL peak particle size and glucose and insulin levels in this nondiabetic population, these correlations accounted for <10% of the variance in LDL peak particle diameter.
The increase in plasma glucose levels during the OGTT is consistent with a greater degree of glucose intolerance in men with LDL pattern B compared with men with pattern A. Indeed, 24 of the 49 men (49%) with LDL pattern B had a plasma glucose level at 120 minutes >140 mg/dL compared with 27 of 111 (24%) men with LDL pattern A (* 2 =9.5, P<.005). Using ANCOVA, the differences in glucose tolerance and insulin levels between men with LDL patterns B and A persisted after adjustment for WHR and Vo 2 max. Thus, the association between LDL subclass pattern B with glucose intolerance and hyperinsulinemia could not be accounted for by differences in obesity and cardiovascular fitness between groups.
Relation of Lipoprotein Lipid Levels to Plasma Insulin Concentrations and Body Composition
To determine whether the regression lines delineating the relations between plasma lipoprotein lipid concentrations and percent body fat, WHR, and insulin differed, ie, were not coincident, in men with LDL patterns B versus A, multiple linear regression analysis with interaction was performed with LDL pattern as a dichotomous variable (Table 4 ). There was no significant relation between HDL-C and WHR in men with LDL pattern B (r=-.10, />=NS), whereas this relation was significant in men with LDL pattern A (r= -.61, P<.001; Fig 1) . Both the slope and intercept of the regression equations describing the relation of HDL-C to WHR differed significantly between LDL patterns B and A (/><.001). The regression equations calculated for the relation between HDL-C and percent body fat also differed between the groups (Fig 2) ; the intercept for HDL-C was 15 mg/dL (0.39 mmol/L) lower in men with LDL pattern B than A (P<.005), resulting in noncoincident regression lines for patterns B and A. At each percent body fat, therefore, plasma HDL-C concentrations were lower in men with LDL pattern B than A. Similarly, the regression equations delineating the relations between logi 0 TG and WHR (Fig 3) and between log 10 TG and percent body fat (Fig 4) The relations of plasma TG and HDL-C levels to plasma insulin concentrations also differed significantly between men with LDL patterns B and A. For plasma HDL-C, both the slope and the intercept of the regression equations delineating the relation between plasma HDL-C levels and fasting plasma insulin concentrations differed significantly (Fig 5A) . The y intercept of the regression equation relating HDL-C to plasma insulin concentration was 15 mg/dL (0.39 mmol/L) lower in men with LDL pattern B than LDL pattern A (F<.001). At each plasma insulin level, therefore, HDL-C levels were lower in men with LDL pattern B than LDL pattern A. Similarly, the men with LDL pattern B had lower HDLa, levels at each plasma insulin concentration than men with LDL pattern A (P<.001, data not shown). The y intercept of the regression equation relating log 10 TG to plasma insulin concentration was 46 mg/dL (0.52 mmol/L) higher for LDL pattern B than for LDL pattern A (P<.001), with no significant difference between the slopes (F<.59; Fig 5B) . Therefore, for a given plasma insulin level, the plasma TG concentration was higher in men with LDL pattern B than LDL pattern A. Thus, the relations between plasma lipoprotein lipid levels and plasma insulin and body composition in this nondiabetic population differed significantly between men with LDL patterns B and A. The data shown in Tables 1, 2 , and 4 are reanalyzed in Tables 5, 6 , and 7, respectively, in the "Appendix" by excluding subjects with the intermediate LDL pattern (255 to 260 A).
Discussion
Men with LDL pattern B had higher plasma TG concentrations, lower HDL-C and HDL 2 subspecies levels, and higher glucose and insulin levels than men with LDL subclass pattern A. These differences in lipoprotein lipid levels persisted after adjustment for differences in WHR and Vo 2 max. Furthermore, the relations between plasma TG, HDL-C, and the HDL 2 subspecies levels with body composition and plasma insulin levels were altered, with higher plasma TG and lower HDL-C and HDL 2 subspecies levels noted in men with LDL pattern B than in those with LDL pattern A for each plasma insulin concentration and for a given degree of obesity. This suggests that the regulation of TG and HDL metabolism by insulin is abnormal in men with LDL pattern B. This is the first time to our knowledge that this difference in relations between lipoprotein lipid concentrations and body composition and plasma insulin levels has been reported in individuals with small LDL particles. Genetic factors may play a role in the pathogenesis of the altered relation between lipoprotein lipid levels, body composition, and plasma insulin concentrations. Studies by Austin et al 4 ' 6 show that the LDL subclass B pattern may be inherited as a single-gene trait. Nishina et al 37 pattern B and a locus (lipoprotein-associated atherosclerosis susceptibility) on chromosome 19 that is close to both the LDL receptor and insulin receptor. In addition, the relation between plasma TG and plasma insulin levels is abnormal in patients with familial hypertriglyceridemia, 17 in women with the apolipoprotein E4 allele, 38 and in patients with renal failure undergoing chronic hemodialysis. 39 Therefore, although the etiology of the metabolic abnormalities in LDL pattern B is not known, our findings suggest that glucose intolerance and genetic differences in the regulation of TG and HDL metabolism by insulin reduce plasma HDL-C and raise TG levels in men with small LDL particles. Thus, the development of abdominal obesity and physical deconditioning with aging would have particularly deleterious effects on glucose and lipoprotein metabolism in susceptible individuals with the LDL subclass pattern B "gene."
Individuals with insulin resistance syndrome 40 have a clustering of metabolic disorders including non-insulindependent diabetes mellitus, hypertension, obesity, increased plasma TGs, low HDL-C, and small LDL particles. Reaven et al 8 report that healthy adults with LDL pattern B were insulin resistant and had higher glucose, insulin, and TG levels, lower HDL-C levels, and higher blood pressure than individuals with either LDL pattern A or the intermediate LDL pattern. Similarly, in the biethnic population of the San Antonio Heart Study 9 small LDL particle size was associated with increased fasting and 2-hour insulin concentrations in both men and women independent of TG and HDL-C levels. In the Kaiser Permanente Women Twins Study 7 there was a graded association between the number of manifestations of insulin resistance syndrome (elevated TG, low HDL-C, and elevated fasting plasma insulin levels and elevated WHR) and the prevalence of LDL pattern B. It is noteworthy that in the present study, even after the exclusion of individuals with hypertension and diabetes mellitus, there was an association between abdominal obesity, insulin resistance, dyslipidemia, and small LDL particles. This observation provides further evidence that there is a spectrum of metabolic abnormalities associated with insulin resistance syndrome. A number of studies support the hypothesis that age, gender and hormonal status, abdominal obesity, physical deconditioning, diet, and other lifestyle variables modulate the penetrance of the LDL B subclass pattern. 44 Therefore, interventions such as weight loss and exercise training, which increase insulin sensitivity, should improve the dyslipoproteinemia in individuals with small LDL particles. In morbidly obese women who underwent gastric bypass surgery 15 there was an increase in LDL size and a decrease in LDL density after weight loss. In a study that examined the effects of exercise on lipoprotein lipids, neither HDL-C levels nor 45 presumably because many of the subjects failed to achieve a sufficient level of training. However, there were significant correlations between changes in LDL flotation rates and changes in TG and HDL levels and an inverse relation between changes in the buoyant LDL-I and dense LDL-III subclasses. The results of the cross-sectional regression analyses in this study suggest that the change in TG and HDL levels in response to weight loss and exercise intervention should differ in individuals with LDL patterns A and B. Intervention studies are in progress to test this hypothesis. In summary, older men with LDL pattern B had a higher WHR, lower V^rnax, higher plasma TG and lower HDL-C concentrations, and an increased prevalence of hyperinsulinemia and glucose intolerance than men with LDL pattern A. The relations of plasma TG and HDL concentrations to plasma insulin levels and body composition differed between the men with LDL patterns B and A. Although the cellular mechanisms for LDL indicates low-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; WHR, waist-to-hip ratio; IRI, immunoreactive insulin; and TG, trlglycerides. Data were analyzed by using multiple linear regression with interaction with LDL pattern as the dichotomous variable.
the metabolic abnormalities associated with the LDL B phenotype are not known, our findings suggest that interventions such as weight loss and aerobic exercise, which reduce abdominal obesity and improve insulin sensitivity, should lower TG levels and raise HDL-C levels in men with small LDL particles. This could lower the risk for coronary artery disease in patients with the LDL B phenotype.
